These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27035419)

  • 1. MAP30 inhibits autophagy through enhancing acetyltransferase p300 and induces apoptosis in acute myeloid leukemia cells.
    Qian S; Sun L; Li J; Wu J; Hu G; Han Y; Yu K; Zhang S
    Oncol Rep; 2016 Jun; 35(6):3705-13. PubMed ID: 27035419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Α-MMC and MAP30, two ribosome-inactivating proteins extracted from Momordica charantia, induce cell cycle arrest and apoptosis in A549 human lung carcinoma cells.
    Fan X; He L; Meng Y; Li G; Li L; Meng Y
    Mol Med Rep; 2015 May; 11(5):3553-8. PubMed ID: 25573293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis.
    Chan DW; Yung MM; Chan YS; Xuan Y; Yang H; Xu D; Zhan JB; Chan KK; Ng TB; Ngan HY
    Pharmacol Res; 2020 Nov; 161():105157. PubMed ID: 32814169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribosome-inactivating Protein MAP30 Isolated from
    Zhou Y; Yang D; Qiang Z; Meng Y; Li R; Fan X; Zhao W; Meng Y
    Recent Pat Anticancer Drug Discov; 2024; 19(2):223-232. PubMed ID: 36330636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and purification of a recombinant ELRL-MAP30 with dual-targeting anti-tumor bioactivity.
    Chen WW; Zhang HR; Huang ZG; Zhou ZY; Lou QW; Jiang XY; Zhu ZH
    Protein Expr Purif; 2021 Sep; 185():105893. PubMed ID: 33933613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of an antitumor and antivirus agent: chemical modification of α-MMC and MAP30 from Momordica Charantia L. with covalent conjugation of polyethyelene glycol.
    Meng Y; Liu S; Li J; Meng Y; Zhao X
    Int J Nanomedicine; 2012; 7():3133-42. PubMed ID: 22802682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Momordica charantia MAP30 and its antitumor effect on bladder cancer cells.
    Hlin H; Zhi-Guo Z; Cong-Hui H; Yan Z; Qing L; Bo J; Hou-Guang H; Jun-Jie Z; Pei-Ying Z
    Minerva Urol Nefrol; 2016 Jun; 68(3):275-81. PubMed ID: 25517785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The heparin-binding domain of HB-EGF as an efficient cell-penetrating peptide for drug delivery.
    Luo Z; Cao XW; Li C; Wu MD; Yang XZ; Zhao J; Wang FJ
    J Pept Sci; 2016 Nov; 22(11-12):689-699. PubMed ID: 27739168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MAP30 protein from bitter gourd (Momordica charantia) seeds promotes apoptosis in liver cancer cells in vitro and in vivo.
    Fang EF; Zhang CZ; Wong JH; Shen JY; Li CH; Ng TB
    Cancer Lett; 2012 Nov; 324(1):66-74. PubMed ID: 22579806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAP30 Inhibits Bladder Cancer Cell Migration and Invasion
    Zhang S; Shi Z; Pang K; He H; Chen J; Zhang Z; Zhang Q; Hao L; Han C
    DNA Cell Biol; 2020 Nov; 39(11):1948-1960. PubMed ID: 33155841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T315 Decreases Acute Myeloid Leukemia Cell Viability through a Combination of Apoptosis Induction and Autophagic Cell Death.
    Chiu CF; Weng JR; Jadhav A; Wu CY; Sargeant AM; Bai LY
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27537872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quercetin simultaneously induces G
    Chang JL; Chow JM; Chang JH; Wen YC; Lin YW; Yang SF; Lee WJ; Chien MH
    Environ Toxicol; 2017 Jul; 32(7):1857-1868. PubMed ID: 28251795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel method for simultaneous production of two ribosome-inactivating proteins, α-MMC and MAP30, from Momordica charantia L.
    Meng Y; Lin S; Liu S; Fan X; Li G; Meng Y
    PLoS One; 2014; 9(7):e101998. PubMed ID: 25003606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mono-PEGylation of Alpha-MMC and MAP30 from Momordica charantia L.: Production, Identification and Anti-Tumor Activity.
    Sun Y; Sun F; Li J; Wu M; Fan X; Meng Y; Meng Y
    Molecules; 2016 Oct; 21(11):. PubMed ID: 27809255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethyl acetate extract of Caesalpinia sappan L. inhibited acute myeloid leukemia via ROS-mediated apoptosis and differentiation.
    Ma HY; Wang CQ; He H; Yu ZY; Tong Y; Liu G; Yang YQ; Li L; Pang L; Qi HY
    Phytomedicine; 2020 Mar; 68():153142. PubMed ID: 32045840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of recombinant MAP30 on cell proliferation and apoptosis of human colorectal carcinoma LoVo cells.
    Fan JM; Luo J; Xu J; Zhu S; Zhang Q; Gao DF; Xu YB; Zhang GP
    Mol Biotechnol; 2008 May; 39(1):79-86. PubMed ID: 18246454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penfluridol triggers cytoprotective autophagy and cellular apoptosis through ROS induction and activation of the PP2A-modulated MAPK pathway in acute myeloid leukemia with different FLT3 statuses.
    Wu SY; Wen YC; Ku CC; Yang YC; Chow JM; Yang SF; Lee WJ; Chien MH
    J Biomed Sci; 2019 Aug; 26(1):63. PubMed ID: 31470848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An inhibitor of the acetyltransferases CBP/p300 exerts antineoplastic effects on gastrointestinal stromal tumor cells.
    Gu ML; Wang YM; Zhou XX; Yao HP; Zheng S; Xiang Z; Ji F
    Oncol Rep; 2016 Nov; 36(5):2763-2770. PubMed ID: 27633918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon.
    Lee-Huang S; Huang PL; Chen HC; Huang PL; Bourinbaiar A; Huang HI; Kung HF
    Gene; 1995 Aug; 161(2):151-6. PubMed ID: 7665070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone acetyltransferase p300/CBP inhibitor C646 blocks the survival and invasion pathways of gastric cancer cell lines.
    Wang YM; Gu ML; Meng FS; Jiao WR; Zhou XX; Yao HP; Ji F
    Int J Oncol; 2017 Dec; 51(6):1860-1868. PubMed ID: 29075795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.